NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its first quarter revenues were up two percent year over year, driven by increased sales for its Oncotype DX tests.

The Redwood City, California-based molecular diagnostics firm brought in total revenues of $68.2 million for the three months ended March 31, up from $67 million in the first quarter of 2014 but below the consensus Wall Street estimate of $69.9 million. All of its revenue in the quarter came from product sales.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.